Peptic Ulcer Disease Clinical Trial
Official title:
A Phase I, Open-Label, Randomized, Single-Centre, 3-Way Crossover Bioequivalence Study Comparing a Fixed Dose Combination Capsule of Esomeprazole 40 mg and Acetylsalicylic Acid 325 mg With Free Combinations of Esomeprazole Capsule 40 mg and Acetylsalicylic Acid Tablet 325 mg and Esomeprazole Tablet
The purpose of this study is to investigate whether treatment with a combination capsule of Esomeprazole 40 mg and Aspirin (ASA) 325 mg is bioequivalent (i.e.has the same effect within the body) as these medications taken separately. Two different forms of esomeprazole (tablets and capsules) will be investigated.
n/a
Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
| Completed |
NCT02716025 -
Serum Zinc, Peptic Ulcer Disease and H. Pylori Infection
|
N/A | |
| Terminated |
NCT01015729 -
Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately
|
Phase 1 | |
| Completed |
NCT02165488 -
Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae
|
||
| Recruiting |
NCT03320538 -
Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases
|
N/A | |
| Completed |
NCT02332213 -
Volatile Markers in Digestive Cancer
|
||
| Completed |
NCT05618249 -
Inventory of Inappropriate Prescriptions of Proton Pump Inhibitors (PPIs) in People Over 75 Years of Age
|
||
| Completed |
NCT04918472 -
Minimally Invasive Evaluation of Dyspepsia by Combined Magnetically Controlled Capsule Endoscopy and Urea Breath Test: a Pilot Prospective Cohort Study
|
N/A |